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Expression of p300-truncated fragments results in the modula- such as chronic glomerulonephritis, diabetic nephropa-
tion of apoptosis in rat mesangial cells. thy, and nephrosclerosis. Examples of altered mesangial
Background. Mesangial cell proliferation, apoptosis, and cell behavior include increased matrix deposition in dia-matrix deposition have pivotal roles in the pathogenesis of
betic nephropathy [1], increased proliferation in chronicrenal diseases such as diabetic nephropathy and glomerulone-
phritis. The behavior of mesangial cells depends on the integra- glomerulonephritis, and decreased apoptosis in lupus ne-
tion of intracellular signals elicited by hormones and cytokines. phritis [2]. The altered behavior is not a consequence of
We hypothesized that p300 is primarily involved in the integra- a primary disease process in the mesangial cells, buttion of signal transduction pathways in rat mesangial cells
rather a response to extracellular signals mediated by(RMCs) and that interference with p300 function will alter
apoptotic signals. hormones, cytokines, and matrix components [3]. Tran-
Methods. We established an RMC cell line expressing the scriptional stimulation in response to cytokines, stress,
Tet-activator (tTA). RMC-tTA cells were transiently trans- retinoids, and steroids is mediated through the p300 pro-fected with vectors coding for either the N-terminal third or
tein [4–6]. p300 and its closely related cAMP-responsivethe C-terminal third of p300. Expression was induced by the
addition of doxycycline [Dox; 1 mg/mL; 5% fetal bovine serum element binding protein (CREB)–binding protein, CBP,
(FBS)]. The percentage of apoptosis was determined using the are ubiquitous, evolutionarily conserved proteins that
TUNEL technique. Specific protein–protein interactions were function, at least in part, by linking several differentdetermined by Western blot analysis of immunoprecipitated
signal responsive transcriptional activators to the basalcomplexes. Cells were treated with 5% FBS or with H2O2 (500
mmol/L, 1 h) with and without Dox. transcription machinery [7–11]. In addition, p300/CBP
Results. The expression of p300-C resulted in increased sus- appears to serve as a switching molecule involved in
ceptibility to low serum-induced (20.0 6 4.6 vs. 3.0 6 1.7%) integrating multiple signal transduction pathways withinand to H2O2-induced apoptosis (75.3 6 13.3 vs. 50.8 6 6.5%)
the nucleus. Activation of cellular Ras with insulin orcompared with controls. Immunoprecipitation of p300-C
showed an interaction with the transcription factor c-Fos, which nerve growth factor (NGF) results in the recruitment of
was enhanced by H2O2 treatment. Expression of the p300-N the S6 kinase pp90rsk into a complex with p300/CBP [12].
resulted in a rescue (34.8 6 6.4 vs. 50.8 6 6.5%) from H2O2- In turn, the pp90rsk-p300/CBP complex represses tran-induced apoptosis compared with controls. P300-N was shown
scription of cAMP-responsive genes. Inasmuch as theto form a complex with the transcription factor nuclear
factor-kB (NF-kB). data indicate that p300/CBP determines which transcrip-
Conclusions. The data indicate that endogenous p300 is in- tional pathways will be activated, the fidelity of its func-
volved in apoptosis in mesangial cells. We propose that interfer- tion is vital for the maintenance of tissue integrity.ence or enhancement of endogenous p300 function, by expres-
We propose that under pathologic conditions, whension of exogenous fragments, can alter interactions with c-Fos
or NF-kB and modulate signals during cellular stress. an abundance of mediators simultaneously engage a mul-
titude of intracellular pathways, signaling fidelity would
be compromised and that the cell would receive mixed
Glomerular mesangial cells play a central role in the signals, that is, activation of signals through the cAMP
pathogenesis of many important forms of kidney disease, pathway coincident with activation of signals through
the Ras pathway. This could result in loss of homeostasis,
Key words: c-Fos, NF-kB, p300 protein, apoptosis, mesangial cells. manifested as aberrant transcriptional changes, prolifer-
ation, and/or death.Received for publication July 22, 1999
Based on this idea, we hypothesized that p300 mediatesand in revised form November 12, 1999
Accepted for publication November 29, 1999 cellular signals to undergo apoptosis in mesangial cells
and that modulation of p300 function will block cell deathÓ 2000 by the International Society of Nephrology
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Fig. 1. A schematic representation of p300/
CBP and reported proteins that interact with
either the N-terminal or C-terminal portions
of the molecule.
signals. To test this, disruption/modulation of p300 func- protein has been associated with apoptotic cell death
tion was achieved by exogenously expressing p300 frag- induced in response to cellular injury [23, 24]. In our
ments, with the assumption that the fragments would com- earlier studies, we showed that c-Fos is actively involved
pete with endogenous p300 for binding to endogenous in the activation of apoptosis in a p53-dependent pathway
transcription factors. We have employed a tetracycline- [25]. A role for p53 in mesangial cell apoptosis has been
inducible system for the expression of the p300 fragments implicated in response to superoxide radicals, and the p53
[13]. In vitro, the tetracycline-responsive system has been pathway has been linked to p300/CBP function [26, 27].
shown to be advantageous for gene expression studies We report the novel finding that overexpression of the
[14], and in vivo, it has been used as an approach for C-terminal fragment of p300 in RMC-tTA cells resulted
gene targeting in the renal glomerulus [15]. Once the in an increased sensitivity to low serum- and H2O2-inducedgene of interest is subcloned into the appropriate vector,
apoptosis. Our results suggest that stress-induced changes
activation is achieved by the addition of tetracycline or
in mesangial cells in a diseased environment can be mod-doxycycline (Dox), to a previously established clonal cell
ulated by interference with transcription factor–p300line expressing a bacterial tetracycline repressor fused
interactions.to a viral VP16 transactivator, tTA. In the presence of
Dox, the Tet-On activator will bind to sequences con-
taining a Tet-operator (Tet O) juxtaposed to a minimal
METHODSpromoter.
Establishment of Tc-responsive p300 vectorsIn the studies presented here, hydrogen peroxide
(H2O2) was used as a signal inducer, chosen on the basis The spontaneously immortalized rat mesangial cell
of published data showing that H2O2 plays a significant line RMC was a generous gift from Dr. R.J. Johnson
role in glomerular disease [16–18]. Stimulation of a H2O2- (University of Washington Medical Center, Seattle, WA,
responsive signal transduction pathways can result in USA). The complete cDNA of p300, provided in a CMVb
activation of transcription factors, including nuclear vector, was a gift from Dr. Richard Eckner (Dana-Farber
factor-kB (NF-kB) and c-Fos, in glomerular mesangial Cancer Institute, Seattle, WA, USA). A 3134 bp frag-
cells [18, 19].
ment, comprising nucleotides 5913 to 9046 (aa 1572 toNuclear factor-kB, which binds the N-terminal domain
2414) was generated by endonucleases Sma I and HINDof p300 (Fig. 1) [20] is a heterodimeric protein composed
III (New England Biolabs, Beverly, MA, USA). A frag-of 50 and 65 kD subunits. The p65 subunit (RelA) inter-
ment of 2229 bp, comprising nucleotides 1200 to 3429acts with p300 [6]. NF-kB is an inducible transcriptional
(aa 1 to 743), was generated by endonucleases Sac I andactivator critical in the regulation of gene expression in
Sma I (New England Biolabs). Purified fragments wereresponse to injury and inflammatory stimuli [21].
blunted and cloned into the EcoRI site of the pTREc-Fos, which binds the C-terminal domain of p300
expression vector (Clontech, Palo Alto, CA, USA). A(Fig. 1) [22], is a member of the activator protein-1 (AP-1)
correct sequence of constructs, pTRE-Dp300C andtranscription factor complex. In addition to a primary
role in normal development and cellular growth, c-Fos pTRE-Dp300N, was confirmed by sequencing.
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Cell culture were lyzed in modified NP-40 lysis buffer [25 mmol/L
HEPES (pH 7.5), 12.5 mmol/L MgCl2, 150 mmol/L KCl,The RMC-tTA cell line was cultured in RPMI 1640
0.5% NP-40, 1 mmol/L dithiothreitol] containing 10 mg ofmedium (GIBCO BRL, Grand Island, NY, USA), sup-
leupeptin per mL, 1% aprotinin, and 0.5 mmol/L phenyl-plemented with bovine insulin (0.67 U/mL; GIBCO
methylsulfonyl fluoride. Glycerol was added to a finalBRL), sodium pyruvate (89 mg/mL; GIBCO), l-gluta-
concentration of 10%. After incubation (1 h at 48C),mine (200 mmol/L; GIBCO), sodium bicarbonate solu-
extracts were centrifuged at 6000 r.p.m. for 15 minutes,tion 7.5%, HEPES (10 mmol/L), fetal bovine serum
and supernatants were collected. The precleared extract(FBS; 18%; Sigma), and 400 mg/mL G418 (GIBCO) and
was incubated with the anti–c-Fos antibody or anti–NF-kBwas incubated at 378C in 10% CO2 in air.
antibody overnight at 48C. Immune complexes were pre-
Generation of tTA-expressing (Tet-On) clones cipitated using protein A-agarose. Pellets were washed
three to five times in lysis buffer and eluted in 1.5 3Rat mesangial cells were trypsinized and replated 24
Lammeli sample buffer. Samples were analyzed by West-hours prior to transfection. The Tet-On vector was trans-
ern blot.fected into RMCs by electroporation, which was per-
formed in serum-free medium with 300 V at a capacitance
Antibodiesof 960 mF (Gene Pulser, BRL, Grand Island, NY, USA).
Transfection efficiencies determined by staining cells Anti-p300 mouse monoclonal antibody (Power-clone),
transfected with the b-galactosidase gene ranged from specific for the C-terminal portion of endogenous p300,
25 to 40%. For each transfection, 8 3 106 cells were was purchased from Upstate Biotechnology (Lake Placid,
mixed with 30 mg of DNA in a volume of 0.6 mL. G418- NY, USA). Rabbit polyclonal anti–N-terminal p300,
resistant clones were expanded, and the integrity of the polyclonal anti–C-terminal p300, polyclonal anti–c-Fos,
regulating element was tested using a luciferase gene and polyclonal NF-kB antibodies were purchased from
reporter assay, the Promega Luciferase Assay System Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
(Promega Corp., Madison, WI, USA). Out of 40 tested
Analysis and quantitation of apoptosisclones, 8 exhibited differential expression of luciferase
proportional to the Dox concentration in the medium. Rat mesangial-tTA cells were transfected with vectors
The selected clones were maintained in medium con- pTRE-Dp300C, pTRE-Dp300N, and pTRE-Dp-lucifer-
taining G418 to preserve the indelibility. Long-term sta- ase. DNA fragmentation was analyzed on combined
bility was not determined since cell cultures had not been attached and detached cells using an apoptosis detection
maintained for more than three months. In addition, kit from Pharmingen (San Diego, CA, USA). In brief,
Western analysis of protein expression was performed apoptotic cells were labeled by the catalytic incorpora-
using Dox at concentrations of 0.25, 0.5, 0.75, 1.0, 2.5, tion of fluorescein-12-dUTP at the 39-OH ends using the
5.0, and 7.5 mg/mL. Cells were transfected with pTRE- enzyme terminal deoxynucleotidyl transferase. Positive
Dp300C and incubated for 24 hours in medium plus 18% cells were quantitated by flow cytometry. Clumps and
FBS. The medium was changed to 5% FBS plus or minus doublets were excluded from the analysis by using for-
Dox, and the cells were incubated an additional 16 hours. ward scatter versus side scatter.
Cell lysates were prepared for protein analysis.
Protein extraction and immunoblotting RESULTS
Cells were incubated without or with Dox (3 mg/mL Modifiable expression of the p300-N and -C terminal
in 18% FBS or 1 mg/mL in 5% FBS) for 16 to 18 hours. fragments in rat mesangial-tTA cells
Adjusted Dox concentrations reflected the reduced total
To determine the efficacy of the Dox-inducible systemprotein in the culture medium. Cells were rinsed twice
in mesangial cells, the first step was to establish a clonalin cold PBS. A volume of sodium dodecyl sulfate (SDS)-
cell line of RMCs that expressed the tetracycline (orpolyacrylamide gel Laemmli sample buffer (1008C) was
Dox) transactivator (tTA) protein. The tTA vector wasadded directly to cells to achieve a final concentration
transfected into RMCs. Forty G418 resistant clones wereof 3 3 106 cells/mL. Cell lysates were collected, boiled
isolated. Clones were transfected with a luciferase re-for five minutes, and sonicated. Aliquots equal to 2 3
porter construct and evaluated for controlled expression105 cells were subjected to SDS-polyacrylamide gel elec-
of luciferase proportional to Dox concentration andtrophoresis at 150 V for one hour and transferred to
eight clones were identified. Figure 2A shows that pro-nitrocellulose at 100 V for 45 minutes in transfer buffer.
tein expression levels are proportional to the Dox con-
Analysis of immune complexes centration (lanes 1 through 8 at doses of 0 mg/mL, 0.25
by immunoprecipitation mg/mL, 0.5 mg/mL, 0.75 mg/mL, 1.0 mg/mL, 2.5 mg/mL,
5.0 mg/mL, and 7.5 mg/mL) in clone A14, the clone usedRat mesangial-tTA cells were transiently transfected,
and after 24 hours were placed in Dox for 18 hours. Cells in the studies presented here. Substantial induction was
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Fig. 2. (A) Protein expression levels of p300-C
are proportional to the doxycycline (Dox)
concentration. Lane 1, 0 mg/mL; lane 2, 0.25
mg/mL; lane 3, 0.5 mg/mL; lane 4, 0.75 mg/mL;
lane 5, 1.0 mg/mL; lane 6, 2.5 mg/mL; lane 7,
5.0 mg/mL; and lane 8, 7.5 mg/mL. Protein
loading controls are shown below. (B) West-
ern blot analysis showing inducible expression
of p300-N (probed with N-terminal specific
antibody), p300-C (probed with p300-C spe-
cific antibody), and luciferase-expressing con-
trols (probed with p300-N specific antibody)
in RMC-tTA cells, with and without Dox.
Western blots were standardized by cell num-
ber (1.2 3 105 per lane). Blots were reprobed
for ERK kinase (p44 to p46) to determine
loading efficiency.
Table 1. Percent apoptosis in transiently transfected RMC-tTA cellsobserved at concentrations higher than 0.75 mg/mL (lane
treated with DOX (1 mmol/L) for 18 hours
4) up to 5 mg/mL (lane 7), but decreased at concentra-
Luciferase P300-N P300-Ctions that approached toxic levels of 7.5 mg/mL (lane 8).
Treatment 1DOX 1DOX 1DOXNo obvious induction was detected in RMC-tTA in the
Low serum 3.061.7% 5.863.7% 20.064.6%absence of Dox. The slight band that is observed in lane
H2O2 50.866.5% 34.866.4% 75.3613.3%1 is a nonspecific band seen also in nontransfected cells
Values were normalized to Luciferase vector controls minus doxycycline(data not shown). Included below the p300-C Western (DOX) of 5% death in low serum and 50% death with H2O2-treatment. Values
were not adjusted for transfection efficiencies, ranging from 25 to 40%. Eachblot is a control band to show protein loading. Thus,
value is the mean 6 standard deviation of three independent experiments.modest concentrations of Dox were sufficient to activate
the exogenous gene activity of the pTRE-Dp300C
vector.
order to keep the Dox concentration at a minimum (DoxThe immunoblots in Figure 2B show that Dox treat-
effectiveness is proportional to total protein concentra-ment (1 mg/mL) of transiently transfected RMC-tTA
tion). We observed that the original RMC populationcells induced expression of the p300-N (80 kD; aa 1-743)
and the RMC-tTA cells were sensitive to decreased con-by 20-fold compared with transfected cells incubated
centrations of FBS. At 5% FBS, there was considerablywithout Dox. Induction of the p300-C (97 kD; aa 1572-
more death in the culture. Also, it appeared that cell2414) resulted in a 25-fold increase in protein levels (Fig.
cultures induced to express p300-C showed many more2B). Cells transfected with the pTRE vector containing
detached cells, as compared with transfected cells with-the luciferase gene were analyzed as controls (Fig. 2B).
out Dox. To test this specifically, transfected RMC-tTAThe blots were reprobed with an anti-ERK (45 kD)
cells were placed in 18 or 5% serum with and withoutantibody to show protein loading.
Dox (3 and 1 mg/mL, respectively). Dox-induced expres-
Functional role of p300-N and p300-C in sion of the p300 fragments had no effect on cell viability
low-serum–induced apoptosis when the cells were incubated under normal proliferative
conditions of 18% FBS. In two separate experiments,During the course of establishing the effective concen-
trations of Dox, the cells were placed in 5% serum in ,1% TUNEL-positive apoptotic cells was detected in
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Fig. 3. P300-C expression results in increased
apoptosis under low serum conditions. (A) A
typical flow cytometry analysis (FACScan)
of apoptotic cells, plotted as FITC-dUTP
(TUNEL positive), verses forward scatter.
Cells were treated with Dox 18 hours in 5%
FBS. (B) Western analysis: Lane 1 contains
cell lysates from luciferase vector transfected
controls. Lane 2 contains attached cell lysates.
Lane 3 contains lysates from cells detached at
the time of harvest.
all groups (data not shown). Evaluation of cells placed
in 5% FBS showed that expression of the p300-N frag-
ment had no significant effect on cell death (Table 1),
compared with luciferase transfected controls (3.0 6
1.4% vs. 5.8 6 3.7%, respectively). In contrast, expres-
sion of p300-C resulted in an increase in apoptosis to
20.0 6 4.0%. A typical flow cytometric analysis of apo-
ptotic cells is shown in Figure 3A as a dot blot, plotted
as TUNEL positive (FITC-dUTP) cells versus forward
scatter (FSC-H). When considering that the transfection
efficiencies ranged from 25 to 40%, an increase of approx-
imately 15% is substantial. In addition, Western analysis
(Fig. 3B) showed that a large fraction of cells expressing
the p300-C protein were found in the detached (D) popu-
Fig. 4. Percent TUNEL-labeled apoptotic RMC-tTA cells incubatedlation, whereas p300-N protein was found primarily in the
in varying concentrations of H2O2 for one hour.attached (A) population. Therefore, the data are consis-
tent with the proposal that p300-C, but not p300-N, is
involved in low serum-induced apoptosis in RMCs.
dying cells. RMC-tTA cells were transfected, incubated
p300-N and p300-C participate in H2O2-induced with Dox plus 5% FBS, and then treated with H2O2 (500
apoptotic pathways mmol/L 1 h). Forced expression of the p300-N fragment
resulted in a 30% reduction in H2O2-induced apoptosisTo establish the sensitivity of RMC-tTA cells to H2O2,
the cells were treated with increasing concentrations of compared with luciferase transfected controls (Table 1).
In contrast, induced expression of p300-C resulted in anH2O2, and apoptosis was measured by TUNEL analysis.
As shown in Figure 4, at 500 mmol/L of H2O2, approxi- approximately 50% increase in H2O2-induced apoptosis
from 50 to 75% as compared with Dox treated, lucifer-mately 40 to 60% of the cells underwent apoptosis. At a
concentration of 700 mmol/L, there were fewer TUNEL- ase-expressing controls. Figure 5A shows a typical flow
cytometric analysis of p300-C transfected cells exposedlabeled cells. We attribute this to increased necrosis at
this dose, based on the morphologic appearance of the to H2O2. Minus Dox shows 34% TUNEL-positive cells,
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Fig. 5. P300-C expression results in increased
apoptosis in the presence of H2O2 (500 mmol/L
for 1 h). (A) Typical FACScan analysis
of apoptotic cells, plotted as FITC-dUTP
(TUNEL positive) versus forward scatter,
comparing percentage death minus Dox ver-
sus plus Dox. (B) Western analysis of p300-C
with and without H2O2. Blot was reprobed
for ERK kinase (pp4 to p46) to show protein
loading.
whereas the addition of Dox resulted in 78% positive present in the p300-N complex (Fig. 6B). Therefore,
human/p300 fragments can associate with rat endoge-cells. To assure that H2O2 treatment did not interfere
with the regulation of the pTRE vectors, Western blot nous transcription factors in intact cells.
analysis for protein expression was performed. H2O2
treatment did not alter the Dox-induced expression of
DISCUSSIONp300-C (Fig. 5B) or p300-N (data not shown).
This study introduces a new concept in the study of
Association of p300 fragments with endogenous intracellular signaling in mesangial cells. The p300 pro-
transcription factors tein is well known to bind multiple transcription factors
in the C-terminal and N-terminal domains of the mole-It was important to know whether the exogenously
cule (Fig. 1). We report the novel finding that p300 isexpressed p300 fragments were binding to the endoge-
involved in H2O2 signaling pathways in mesangial cellsnous transcription factors. To demonstrate the physical
and that these signals can be modulated by forced expres-association of p300-C with c-Fos, we used immunopre-
sion of p300 truncated fragments. Both the N-terminalcipitation-Western blot analysis to detect interactions.
and the C-terminal fragments of p300 were shown toExtracts from cells, transiently transfected with a p300-C
interact with endogenous transcription factors, and bothexpression vector (minus Dox/plus H2O2 and plus Dox
fragments were functionally active. Expression of theplus H2O2), were immunoprecipitated using a p300-C ter-
N-terminal fragment rescued cells from H2O2-inducedminal-specific antibody. The transcription factor c-Fos
apoptosis, while expression of the C-terminal fragmentwas detected in immune complexes precipitated with a
enhanced apoptosis.C-terminal–specific p300 antibody, but only in the pres-
The efficacy to the Tet-On system in RMCs has beenence of Dox (Fig. 6A). These data indicate that endoge-
demonstrated in these studies. The RMC-tTA cells pro-nous c-Fos physically interacts with the recombinant
duced a protein of the anticipated size in response toC-terminal portion of p300. The same approach was
Dox that showed immunoreactivity with p300 antibodies.taken to detect NF-kB/p300-N interactions using a p300
The recombinant proteins formed complexes with acti-N-terminal–specific antibody. Western blot analysis of
immunoprecipitated complexes revealed that NF-kB was vated endogenous transcription factors. Apoptosis was
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apoptosis; however, the opposite effect was observed.
There are at least three possible explanations for the
finding of enhanced death in the presence of p300-C:
c-Fos complexes. First, the truncated fragment may have
unimpaired the ability to initiate transcription, assuming
that the loss of two thirds of the molecule may simply
mean that the regulatory portions of the molecule are
no longer present. However, it is intriguing that the
N-terminal fragment seemed to also be able to form
functional complexes. A second possibility is that the
c-Fos/p300-mediated apoptosis is a nontranscriptional
event, but possibly an activation event leading to even-
tual triggering of caspases. This concept is supported by
our earlier work showing that c-Fos–induced apoptosis
was a nontranscriptional event [25]. Third, the levels of
endogenous p300 are strictly controlled, but it is not
known how they are kept constant. It is reasonable to
assume that overexpression of recombinant fragments
may alter the homeostasis of the endogenous proteins.
In fact, in many experiments the transfection of the N-
terminal fragment appeared to decrease the levels ofFig. 6. p300-C binds c-Fos and p300-N binds NF-kB. RMC-tTA cells
were treated with H2O2 for 15 to 30 minutes plus or minus Dox. (A) endogenous p300 (data not shown) even though this was
Western blot analysis of protein complexes immunoprecipitated with not studied systematically. It is possible that generation
a c-Fos specific antibody from p300-C expressing cells. Western blot
of endogenous p300 fragments is required as part of thewas probed with a p300-C-specific antibody. (B) Western blot analysis of
protein complexes immunoprecipitated with a NF-kB specific antibody, normal apoptotic process. In support of the existence
from p300-N expressing cells. Western blot was probed with a p300-N- of endogenous p300 fragments, a published report has
specific antibody.
described a subspecies (fragment) of p300 (a C-terminal
portion) that could be immunoprecipitated with the
polyomavirus large T antigen [29]. Our data would imply
that this subspecies might have biological activity.modulated by the expression of p300 fragments. It will
be interesting to determine whether overexpression of Two published reports have described phenotypic
changes associated with exogenously expressed p300-C-the whole p300 molecule will result in increased apopto-
sis in the RMCs once the gene is subcloned into the terminal fragments. Fujii et al microinjected RNA of
the carboxy terminal-truncated portion of Xenopus p300pTRE vector. We have shown that overexpression of
p300 in p53 wild-type cells, including Syrian hamster (Xp300) into a blastomere stage embryo and found that
it invoked the malformation of the embryo [30]. Avant-embryo fibroblast cells and human tumor cells, induces
apoptosis (Preston et al, manuscript submitted for publi- aggiati et al showed that cotransfection of p53 in combi-
nation with the C-terminal fragment of p300 blockedcation). The use of the Tet-On system will enable us to
introduce varying amounts of the p300 molecule and the p53-induced apoptosis [31]. These data are in contrast
to our findings of increased death with expression of thep300 fragments into mesangial cells that could interact
with transcription factors, thus modulating the response p300-C-terminal fragment. One explanation would be
that their experiments involved overexpression of p53,to signaling pathways.
It was difficult to predict whether the complexation while our experimental system dealt with endogenous
levels of p53 with overexpression of portions of p300.of the p300 fragments with transcription factors would
lead to attenuation of a response due to sequestration We have not studied p53 in our system as it relates to
overexpression of p300 fragments; however, overexpres-or whether a response would be augmented due to in-
creased amounts of a complex with biological activity. sion of p300 enhances E1 A-induced apoptosis [32]. Also,
Avantaggiati et al used the SAOS human tumor cell lineIt has been reported that preventing AP-1 activation can
block mesangial cell apoptosis [28]. Unpublished data, that is p532/2, as well as Rb2/2. The precise cohort of
genes altered in these tumor cells and the signaling path-which indicated that AP-1 was involved in our system,
showed that c-Fos (a member of the AP-1 transcription ways that have been inactivated/activated will be differ-
ent, and it is unlikely that this cellular system wouldfactor complex) levels were increased in the presence of
H2O2, as determined by TaqMan quantitative reverse respond similarly to our system.
The importance of p300 in the regulation of cellulartranscription-polymerase chain reaction. As such, we an-
ticipated that titration of c-Fos would result in decreased homeostasis is reflected in the fact that multiple viral
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man IG, Juguilon H, Montminy M, Evans RM: Role of CBP/proteins have been shown to bind and to modulate p300
P300 in nuclear receptor signalling. Nature 383:99–103, 1996
function. As shown in Figure 1, these include adenoviral 6. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel
GJ: Regulation of NF-kappaB by cyclin-dependent kinases associ-protein E1 A [7], SV40 large T protein [33], Ebstein
ated with the p300 coactivator. Science 275:523–527, 1997Barr viral protein, zta [34], and T-cell leukemia virus
7. Eckner R, Ewen ME, Newsome D, Gerdes M, Decaprio JA,
type 1 Tax protein [35]. p300/CBP also seems to be Lawrence JB, Livingston DM: Molecular cloning and functional
analysis of the adenovirus E1A-associated 300-kD protein (p300)involved in the mechanism that senses and controls the
reveals a protein with properties of a transcriptional adaptor. Genesrepair of DNA damage. Expression of proliferating cell
Dev 8:869–884, 1994
nuclear antigen (PCNA), a crucial component for DNA 8. Arany Z, Sellers WR, Livingston DM, Eckner R: E1A-associ-
ated p300 and CREB-associated CBP belong to a conserved familypolymerase activity during repair, is activated through a
of coactivators. (letter) Cell 77:799–800, 1994p300/CBP-dependent mechanism [36].
9. Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R:
Our results with H2O2 provide a conceptual basis for A family of transcriptional adaptor proteins targeted by the E1A
oncoprotein. Nature 374:81–84, 1995utilization of this system to determine if other signaling
10. Lundblad JR, Kwok RP, Laurance ME, Harter ML, Goodmanpathways, such as tumor necrosis factor-a, interferon-g,
RH: Adenoviral E1A-associated protein p300 as a functional ho-
or transforming growth factor-b, can be modulated by mologue of the transcriptional co-activator CBP. Nature 374:85–88,
1995expression of p300 fragments. These cytokines are
11. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z,known to activate transcription factors during disease D’Andrea A, Livingston DM: Cooperation of Stat2 and p300/
states. The Smad family of transcription factors, which CBP in signalling induced by interferon- alpha. Nature 383:344–347,
1996interact with p300/CBP (Fig. 1), are intermediate effector
12. Nakajima T, Fukamizu A, Takahashi J, Gage FH, Fisher T,proteins that transduce transforming growth factor-b sig- Blenis J, Montminy MR: The signal-dependent coactivator CBP
nals [37]. Interferon-g stimulates the activity of the Stat is a nuclear target for pp90RSK. Cell 86:465–474, 1996
13. Gossen M, Bujard H: Tight control of gene expression in mamma-family of transcription factors, which also bind p300 (Fig.
lian cells by tetracycline-responsive promoters. Proc Natl Acad Sci1) [38]. USA 89:5547–5551, 1992
In summary, the new findings outlined here indicate 14. Blau HM, Rossi FM: Tet B or not tet B: Advances in tetracycline-
inducible gene expression. Proc Natl Acad Sci USA 96:797–799,that p300 is an important signaling molecule in mesangial
1999cells. Utilization of the RMC-Tet-On system will be in- 15. Kitamura M: Creation of a reversible on/off system for site-specific
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